Case report: Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 8, 1998, Pages 825-829

  Kozaiwa, Kosuke ^a   Tajiri, Hitoshi ^a   Sawada, Atsusi ^a   Tada, Kanae ^a   Etani, Yuri ^a   Miki, Kazunori ^a   Okada, Shintaro ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Primary sclerosing cholangitis; Sulphasalazine; Ursodeoxycholic acid

Indexed keywords

MIZORIBINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID; GASTROINTESTINAL AGENT;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DRUG EFFICACY; HUMAN; LIVER BIOPSY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS; CHILD; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; LIVER FUNCTION TEST; PATHOLOGY; SCLEROSING CHOLANGITIS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; GASTROINTESTINAL AGENTS; HUMANS; LIVER FUNCTION TESTS; MALE; SULFASALAZINE; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0032135138     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00740.x     Document Type: Article

References (24)

1. Johnson DA, Cattau EL, Hancock JE. Pediatric primary sclerosing cholangitis. Dig. Dis. Sci. 1986; 31: 773 -9.
2. Sisto A, Feldman P, Garel I, et al. Primary sclerosing cholangitis in children: study of five cases and review of the literature. Pediatrics 1987; 80: 918-23.
3. Manesme OA, Bernard O, Brunelle F et al. Sclerosing cholangitis with neonatal onset. J. Pediatr. 1987; 111: 225-9.
4. El-Shabrawi M, Wilkinson ML, Portmann B et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92: 1226-35.
5. Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J. Pediatr. 1994; 124: 49-56.
6. Wilschanski M, Chait P, Wade JA et al. Primary sclerosing cholangitis in 32 children: Clinical, laboratory and radiographic features with survival analysis. Hepatology 1995; 22: 1415-22.
7. Hayashi H, Higuchi T, Ichimiya H, Hishida N, Sakamoto K. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology 1990; 99: 533-5.
8. Chazouillers O, Poupon R, Carpon JP et al. Ursodeoxycholic acid for primary sclerosing cholangitis. J. Hepatol. 1990; 11: 120-3.
9. Fromm H. New treatment for primary sclerosing cholangitis: Promising results with ursodiol. Gastroenterology 1992; 103: 343.
10. Stiehl A. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis. Scand. J. Gastroenterol. 1994; 99 (Suppl. 204): 59-61.
11. Ludwing J, La Russo NF, Wiesner RH. Primary sclerosing cholangitis. In: Peters RL, Craig JR eds. Contemporary Issues in Surgical Pathology, Vol. 8: Liver Pathology. New York: Churchill-Livingstone, 1986.
12. La Russo NF, Wiesner RH, Ludwing J, MacCarry RL. Primary sclerosing cholangitis. N. Engl. J. Med. 1984; 310: 899-903.
13. Farrant JM, Hayllar KM, Wilkinson ML et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-17.
14. Olsson R, Broom U, Danielsson A et al. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995; 108: 1199-203.
15. Tamsin A, Knox MD, Marshall M, Kaplan MD. Treatment of primary sclerosing cholangitis with oral methotrexate. Am. J. Gastroenterol. 1991; 86: 546-52.
16. Thiel DH, Carroll P, Elmagd K et al. Tacrolimus (FK506), a treatment for primary sclerosing cholangitis: Results of an open-label preliminary trial. Am. J. Gastroenterol. 1995; 90: 455-9.
17. Poupon R, Chretien Y, Poupon RE et al. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; I: 834-6.
18. Lebovics E, Salama M, Elhosseiny A, Rosenthal WS. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Gastroenterology 1992; 102: 2143-7.
19. Beuers U, Spengler U, Kruis W et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial. Hepatology 1992; 16: 707-14.
20. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J. Hepatol 1994; 20: 57-64.
21. Lindor KD, Mayo Primary Sclerosing Cholangitisursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis. N. Engl. J. Med. 1997; 336: 691-5.
22. Klotz U, Marier K, Fisher C, Heinkei K. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N. Engl. J. Med. 1980; 303: 1499-502.
23. Oriishi T, Sata M, Toyonaga A, Sasaki E, Tanikawa K. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. Gut 1995; 36: 891-6.
24. Mikkola K, Kiviluoto T, Riihela M, Taavitsainen M, Jarvinen HJ. Liver involvement and its course in patients operated on for ulcerative colitis. Hepatogastronterology 1995; 42: 68-72.